Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
OPOption Care Health, Inc. logo

Option Care Health, Inc. (OPCH)

NASDAQ Global Select · Currency in USD
$31.22 ▼ -0.07 (-0.22%)
At close: Oct 23, 4:00 PM ET. Market closed.
$31.22 ▲ +0.00 (+0.00%)
After hours: Oct 23, 7:30 PM ET

Summary

Previous Close
$31.29
Open
$31.31
Day's Range
$31.22 – $31.33
52 Week Range
$18.01 – $36.80
Volume
2,652,076
Avg. Volume
3,424,053
Market Cap
$4.68B
Beta (5Y Monthly)
0.58
PE Ratio (TTM)
23.47
EPS (TTM)
$1.35
Earnings Date
Nov 4, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$28.78

Profile: Option Care Health, Inc.

Sector
Healthcare
Industry
Medical - Care Facilities
Full-time employees
7,397
CEO
John C. Rademacher

Option Care Health, Inc. delivers infusion services to patients in their homes and other non-hospital settings throughout the United States. The company offers a broad spectrum of specialized infusion treatments, including therapies for various infections, management of heart failure, and comprehensive nutritional support (both intravenous and tube feeding) for individuals with acute or chronic conditions such as stroke, cancer, and digestive illnesses. They also provide immunoglobulin infusions for immune system deficiencies and treatments targeting chronic inflammatory disorders like Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis.

Earnings

Next report: Wed, Nov 4, 2026
EPS estimate $0.49 · Revenue est. $1.48B
DateEst.Actual
Jul 29, 2026$0.43$0.45Beat
Apr 30, 2026$0.37$0.40Beat
Feb 24, 2026$0.46$0.46Beat
Oct 30, 2025$0.43$0.45Beat
Jul 30, 2025$0.40$0.41Beat
Apr 29, 2025$0.36$0.40Beat

Analyst view

Consensus price target
$28.78 ▼ -7.8%
Range $22.00 – $32.05
Rating: Hold
Buy 38% · Hold 63% · Sell 0%

Get free alerts on OPCH and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.